Skip to main content
Caplight Logo









Orphina Biotechnology

Orphina Biotechnology

Private
Calabasas, CaliforniaHealthcare & Life Scienceshttps://www.orphina.com/

Company Overview

Orphina Biotechnology is a biotechnology company that develops gene therapies for preserving and prolonging muscle health, with an initial focus on GNE myopathy.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

gene therapyGNE MyopathyGNEMrare diseasenon-viral gene therapymuscle-wasting diseaseorphan drugbiotech startupdrug discoveryclinical developmenttherapeutic pipelineskeletal muscle therapybiotech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Orphina Biotechnology Comparables

Compare Orphina Biotechnology with similar companies based on industry and business-model similarity.

Orphina Biotechnology comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Genosera Inc.
86%
Myosana Therapeutics
84%
Spot Biosystems
82%

Orphina Biotechnology Funding Rounds

Historical fundraising activity

View Full Funding History

Access detailed round history, amounts raised, valuations, and investors.

Orphina Biotechnology Filings

Explore SEC and related filing metadata, where available.

Orphina Biotechnology filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Orphina Biotechnology's valuation, stock price, and market status.

Is Orphina Biotechnology a public or private company?

Orphina Biotechnology is a private company.

What is the current stock price of Orphina Biotechnology?

Orphina Biotechnology is a private company with no public stock price. Caplight tracks Orphina Biotechnology's secondary market activity and provides MarketPrice™ estimates to Caplight users.

How much is Orphina Biotechnology worth (valuation)?

Valuation information for Orphina Biotechnology is not publicly available.

Can I buy Orphina Biotechnology stock?

Orphina Biotechnology shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Orphina Biotechnology's last funding round?

Funding round information for Orphina Biotechnology is not publicly available.

Who are the main investors in Orphina Biotechnology?

Investor information for Orphina Biotechnology is not publicly disclosed.

Will Orphina Biotechnology IPO soon?

No public IPO plans have been announced for Orphina Biotechnology.

How can I track Orphina Biotechnology secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Orphina Biotechnology's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersCalabasas, California
Employee Range2
Year Founded2020
Last Funding—

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?